If you made any changes in Pure these will be visible here soon.

Personal profile

Research interests

To understand how the vascular complications of diabetes develop and progress and how we can target specific pathways to delay, stop or reverse diabetic micro-and macrovascular complications including heart and kidney disease.


  • Diabetes
  • Diabetic complications
  • diabetic nephropathy
  • cardiovascular disease
  • oxidative stress
  • reactive oxygen species
  • unstable plaque
  • novel targets
  • clinical translation

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2014 2022

Research Output 1991 2018

Lipoxins regulate the early growth response-1 network and reverse diabetic kidney disease

Brennan, E. P., Mohan, M., McClelland, A., Tikellis, C., Ziemann, M., Kaspi, A., Gray, S. P., Pickering, R., Tan, S. M., Tasadaque Ali-Shah, S., Guiry, P. J., El-Osta, A., Jandeleit-Dahm, K., Cooper, M. E., Godson, C. & Kantharidis, P., 1 May 2018, In : Journal of the American Society of Nephrology. 29, 5, p. 1437-1448 12 p.

Research output: Contribution to journalArticleResearchpeer-review

Metabolic karma-the atherogenic legacy of diabetes: The 2017 edwin bierman award lecture

Cooper, M. E., El-Osta, A., Allen, T. J., Watson, A. M. D., Thomas, M. C. & Jandeleit-Dahm, K., 1 May 2018, In : Diabetes. 67, 5, p. 785-790 6 p.

Research output: Contribution to journalArticleOther

SGLT-2 Inhibition: Novel Therapeutics for Reno-and Cardioprotection in Diabetes Mellitus

Gill, A., Gray, S. P., Jandeleit-Dahm, K. & Watson, A., 17 Apr 2018, (Accepted/In press) In : Current Diabetes Reviews. 9 p.

Research output: Contribution to journalReview ArticleResearchpeer-review

Combined NOX1/4 inhibition with GKT137831 in mice provides dose-dependent reno- and atheroprotection even in established micro- and macrovascular disease

Gray, S. P., Jha, J. C., Kennedy, K., Bommel, E. V., Chew, P., Szyndralewiez, C., Touyz, R. M., Schmidt, H. H. H. W., Cooper, M. E. & Jandeleit-Dahm, K. A. M., May 2017, In : Diabetologia. 60, 5, p. 927-937 11 p.

Research output: Contribution to journalArticleResearchpeer-review

GLP-1 receptor agonists: An example of the challenge for animal models to predict plaque instability/rupture and cardiovascular outcomes

Ying, Y. L., Chen, Y. C., Jandeleit-Dahm, K. & Peter, K., 1 Oct 2017, In : Atherosclerosis. 265, p. 250-252 3 p.

Research output: Contribution to journalEditorialOtherpeer-review